VCYT
$29.49
Revenue | $130.16Mn |
Net Profits | $-0.98Mn |
Net Profit Margins | -0.75% |
PE Ratio | 88.88 |
Veracyte, Inc.’s revenue jumped 13.75% since last year same period to $130.16Mn in the Q2 2025. On a quarterly growth basis, Veracyte, Inc. has generated 13.71% jump in its revenue since last 3-months.
Veracyte, Inc.’s net profit fell -117.09% since last year same period to $-0.98Mn in the Q2 2025. On a quarterly growth basis, Veracyte, Inc. has generated -113.91% fall in its net profits since last 3-months.
Veracyte, Inc.’s net profit margin fell -115.02% since last year same period to -0.75% in the Q2 2025. On a quarterly growth basis, Veracyte, Inc. has generated -112.23% fall in its net profit margins since last 3-months.
Veracyte, Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 88.88.
EPS Estimate Current Quarter | 0.3 |
EPS Estimate Current Year | 0.3 |
Veracyte, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.3 - a 175.18% jump from last quarter’s estimates.
Veracyte, Inc.’s earning per share (EPS) estimates for the current year stand at 0.3.
Earning Per Share (EPS) | 0 |
Veracyte, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Veracyte, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-08 | -0.17 | 0.31 | 282.35% |
2025-08-06 | 0.11 | 0.44 | 300% |
2025-11-11 | 0.3 | 0 | -100% |